22nd Century Group Appoints James A. Mish as Chief Executive Officer and John Franzino as Chief Financial Officer
Mish brings extensive global executive leadership experience in the development, manufacturing and commercialization of active pharmaceutical ingredients, including cannabinoids, and […]